Vertex Pharmaceuticals Inc Stock Ownership - Who owns Vertex Pharmaceuticals?

Insider buying vs selling

Have Vertex Pharmaceuticals Inc insiders been buying or selling?
Charles F. Wagner Jr.EVP Chief Financial Officer2023-03-17784$295.43
Charles F. Wagner Jr.EVP Chief Financial Officer2023-03-17360$298.09
Charles F. Wagner Jr.EVP Chief Financial Officer2023-03-17240$296.30
Charles F. Wagner Jr.EVP Chief Financial Officer2023-03-17240$299.58
Charles F. Wagner Jr.EVP Chief Financial Officer2023-03-1716$301.13
Charles F. Wagner Jr.EVP Chief Financial Officer2023-03-17360$294.52
Bastiano SannaEVP Cell Genetic Therapies2023-03-16264$301.07
Bastiano SannaEVP Cell Genetic Therapies2023-03-162,482$300.54
Charles F. Wagner Jr.EVP Chief Financial Officer2023-03-13420$292.41
Charles F. Wagner Jr.EVP Chief Financial Officer2023-03-131,153$293.35

1 of 37

VRTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VRTX insiders and whales buy or sell their stock.

VRTX Shareholders

What type of owners hold Vertex Pharmaceuticals Inc stock?
Blackrock Inc9.43%24,241,437$7.25BInstitution
Vanguard Group Inc8.38%21,546,903$6.44BInstitution
Fmr LLC6.95%17,866,291$5.34BInstitution
Capital World Investors4.97%12,769,006$3.82BInstitution
State Street Corp4.81%12,370,430$3.70BInstitution
Alliancebernstein LP3.53%9,069,580$2.71BInstitution
Wellington Management Group LLP2.66%6,827,583$2.04BInstitution
Jpmorgan Chase Co2.14%5,490,408$1.64BInstitution
Geode Capital Management LLC2.09%5,382,719$1.61BInstitution
Jennison Associates LLC1.99%5,115,540$1.53BInstitution

1 of 3

VRTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VRTX91.63%1.52%Net SellingNet Selling
REGN69.97%30.03%Net SellingNet Selling
MRNA64.14%22.31%Net SellingNet Selling
SGEN46.23%53.77%Net SellingNet Selling

Vertex Pharmaceuticals Stock Ownership FAQ

Who owns Vertex Pharmaceuticals?

Vertex Pharmaceuticals (NASDAQ: VRTX) is owned by 91.63% institutional shareholders, 1.52% Vertex Pharmaceuticals insiders, and 6.85% retail investors. Blackrock Inc is the largest individual Vertex Pharmaceuticals shareholder, owning 24.24M shares representing 9.43% of the company. Blackrock Inc's Vertex Pharmaceuticals shares are currently valued at $7.25B.

If you're new to stock investing, here's how to buy Vertex Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.